Is Pennant Group Inc (PNTG) overvalued? · P/E 40, rev $583.3M
Pennant Group Inc (PNTG) is a medical care facilities company listed on NASDAQ.
This page asks whether Pennant Group Inc (PNTG) looks expensive on cached numbers — not a short thesis.
Latest reported PNTG revenue for 2026-06-30 was $583.3M. Net income was $17.6M. PNTG currently screens at market cap $1.20B and trailing P/E 40.2.
PNTG currently screens at market cap $1.20B and trailing P/E 40.2. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next PNTG 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the PNTG stock page for the full model, not this heading.
Not investment advice.